Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ —USA News Group…

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for…

iLive Connect launches India's first 'Doctor-Led Continuous Care' platform – Express Healthcare

iLive Connect, a groundbreaking healthcare innovation, announced its official launch in India, introducing a ‘Doctor-Led Continuous…

Understanding alternative drug funding programs

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ — Equity Insider…

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ — Equity Insider…

Fortis Eye Institute launches Ocular Oncology Clinic – Express Healthcare

Fortis Gurugram Eye Institute at Fortis Memorial Research Institute (FMRI) has launched a dedicated Ocular Oncology…

Why developmental and behavioral pediatrics faces a recruitment collapse

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help…

Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology, Helping People Take Action Earlier to Slow Disease Impact

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help…

Zydus partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India – Express Healthcare

Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has signed an agreement with Myriad…

Why senior-friendly health materials are essential for access

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ –Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI…